User profiles for Erica De Candia
De Candia EricaProfessore Associato di Medicina Interna, Università Cattolica del Sacro Cuore Verified email at unicatt.it Cited by 3721 |
[HTML][HTML] COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET)
The ongoing pandemic of Coronavirus disease 2019 (COVID-19) is severely challenging
healthcare systems all around the world, with the need to provide intensive care to a previously …
healthcare systems all around the world, with the need to provide intensive care to a previously …
[HTML][HTML] Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets
E De Candia, SW Hall, S Rutella, R Landolfi… - Journal of Biological …, 2001 - ASBMB
The activation of human platelets by α-thrombin is mediated at least in part by cleavage of
protease-activated G-protein-coupled receptors, PAR-1 and PAR-4. Platelet glycoprotein Ibα …
protease-activated G-protein-coupled receptors, PAR-1 and PAR-4. Platelet glycoprotein Ibα …
MYH9‐Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype–Phenotype Correlations
…, M De Groot, B Zieger, E De Candia… - Human …, 2014 - Wiley Online Library
MYH 9‐related disease ( MYH 9‐ RD ) is a rare autosomal‐dominant disorder caused by
mutations in the gene for nonmuscle myosin heavy chain IIA ( NMMHC ‐ IIA ). MYH9‐ RD is …
mutations in the gene for nonmuscle myosin heavy chain IIA ( NMMHC ‐ IIA ). MYH9‐ RD is …
Position of nonmuscle myosin heavy chain IIA (NMMHC‐IIA) mutations predicts the natural history of MYH9‐related disease
MYH9‐related disease (MYH9‐RD) is a rare autosomal‐dominant disorder caused by
mutations in MYH9, the gene for the heavy chain of nonmuscle myosin IIA (NMMHC‐IIA). All …
mutations in MYH9, the gene for the heavy chain of nonmuscle myosin IIA (NMMHC‐IIA). All …
Mechanisms of platelet activation by thrombin: a short history
E De Candia - Thrombosis research, 2012 - Elsevier
Platelet activation by thrombin is relevant to arterial thrombosis, therefore it is an attractive
target for the development of new antithrombotic drugs. In the 1970s the platelet membrane …
target for the development of new antithrombotic drugs. In the 1970s the platelet membrane …
Impact of gut microbiota on obesity, diabetes, and cardiovascular disease risk
L Miele, V Giorgio, MA Alberelli, E De Candia… - Current cardiology …, 2015 - Springer
Gut microbiota has been recently established to have a contributory role in the development
of cardiometabolic disorders, such as atherosclerosis, obesity, and type 2 diabetes. Growing …
of cardiometabolic disorders, such as atherosclerosis, obesity, and type 2 diabetes. Growing …
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders
…, M Cattaneo, J Bussel, E De Candia… - Blood, The Journal …, 2014 - ashpublications.org
Abnormalities of platelet size are one of the distinguishing features of inherited
thrombocytopenias (ITs), and evaluation of blood films is recommended as an essential step for …
thrombocytopenias (ITs), and evaluation of blood films is recommended as an essential step for …
[HTML][HTML] Bleeding risk of surgery and its prevention in patients with inherited platelet disorders
…, R Favier, Y Henskens, E De Maistre, E De Candia… - …, 2017 - ncbi.nlm.nih.gov
Excessive bleeding at surgery is a feared complication in patients with inherited platelet
disorders. However, very few studies have evaluated the frequency of surgical bleeding in these …
disorders. However, very few studies have evaluated the frequency of surgical bleeding in these …
[HTML][HTML] Extended coagulation profile of children with Long Covid: a prospective study
…, P Valentini, S Sorrentino, MA Ferretti, E De Candia… - Scientific reports, 2022 - nature.com
Emerging data suggests that endotheliopathy changes can be associated with post covid
condition (PCC) in adults. Research on the matter in children is lacking. We analyzed an …
condition (PCC) in adults. Research on the matter in children is lacking. We analyzed an …
Functional role of protease activated receptors in vascular biology
MA Alberelli, E De Candia - Vascular pharmacology, 2014 - Elsevier
Protease activated receptors (PARs) are a small family of G protein-coupled receptors (GPCR)
mediating the cellular effects of some proteases of the coagulation system, such as …
mediating the cellular effects of some proteases of the coagulation system, such as …